ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

Prostaglandin E2

HCID 5280360
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
22230-04-2
標準SMILES
CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O
InChIKey
XEYBRNLFEZDVAW-ARSRFYASSA-N
分子式
C20H32O5
平均分子量
352.5 g/mol
単同位体質量
352.22497412

概要

Prostaglandin E2 is prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins. It has a role as an oxytocic, a mouse metabolite and a human metabolite. It is a conjugate acid of a prostaglandin E2(1-).

名称と識別子

優先名称
Prostaglandin E2
IUPAC
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
英語名
dl-PGE2
分子式
C20H32O5
分子量
352.47

名称と別名

Prostaglandin E2Dinoprostone363-24-6PGE2Prostin E2PrepidilCervidilMinprostin E2PropessMinprositin E2DinoprostonDinoprostonum
名称をさらに表示
dl-PGE2Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11α,13E,15S)-(+-)-Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11α,13E,15S)-(±)- (9CI)5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-, (+-)- (8CI)
CerviprostDinoprostonaEnzaprost ECerviprimeProstenonePGE2alphaU-12062(5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid

データベース識別子

CAS
22230-04-2、363-24-6
PubChem CID
5280360
DTXSID
DTXSID00859353
ChEMBL
CHEMBL548
ChEBI
CHEBI:15551

物性

構造計算による物性補完中

XLogP
2.8
極性表面積
94.8 Ų
水素結合供与体数
3
水素結合受容体数
5
回転可能結合数
12
重原子数
25
形式電荷
0
複雑度
469

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LipidsFatty Acyls [FA] -> Eicosanoids [FA03] -> Prostaglandins [FA0301]
LogP · 2 件

2.82

2.9

Human Drugs · 4 件

Breast Feeding; Lactation; Milk, Human; Oxytocics; Prostaglandins

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Medicines administered to the neonate [c]

Melting Point67 °C
Physical DescriptionSolid
Dissociation Constants4.77
Collision Cross Section · 3 件

188.9 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Calculation: Single Field; Dataset: Oxylipins]

192.06 Ų [M-H]- [CCS Type: DT; Method: stepped-field]

183.57 Ų [M-H2O-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

物理化学的性質

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 79 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

Adverse Effects · 1 件

The most common side effects of prostaglandin E2 concern its impact on gastrointestinal smooth muscle. The suppository correlates with the most severe side effects, with two-thirds of patients experiencing vomiting, two-fifths experiencing diarrhea, and one-third experiencing nausea. Other adverse effects include temperature elevation in half of the patients, headache in one-tenth, and shivering and chills in one-tenth. Anti-emetics and anti-diarrheal medications may be necessary before and during the drug administration to counteract these side effects.

Toxicity SummaryProstaglandin E2 overdose typically manifests as uterine hyperstimulation, and stopping the drug is the most effective treatment. Also, beta-adrenergic drugs, such as terbutaline, may be used in case of continued symptoms.
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

化学と産業

薬理情報

ATC Code · 4 件

G02AD02

G - Genito urinary system and sex hormones

QG - Genito urinary system and sex hormones

G02AD02

Protein Binding73%, to albumin
Pharmacodynamics · 1 件

Dinoprostone is equivalent to prostaglandin E2 (PGE2). It stimulates labor and delivery by stimulating the uterine, and thus terminates pregnancy. Dinoprostone is also capable of stimulating the smooth muscle of the gastrointestinal tract of man. This activity may be responsible for the vomiting and/or diarrhea that is not uncommon when dinoprostone is used to terminate pregnancy.

Mechanism of Action · 1 件

Dinoprostone administered intravaginally stimulates the myometrium of the gravid uterus to contract in a manner that is similar to the contractions seen in the term uterus during labor, resulting in the evacuation of the products of conception from the uterus. It is believed that dinoprostone exerts its uterine effects via direct myometrial stimulation, but the exact mechanism of action is unkown. Other suggested mechanisms include the regulation of cellular membrane calcium transport and of intracellular concentrations of cyclic 3',5'-adenosine monophosphate. Dinoprostone also appears to produce local cervical effects including softening, effacement, and dilation. The exact mechanism of action for this effect is also unknown, but it has been suggested that this effect may be associated with collagen degradation caused by secretion of the enzyme collagenase as a partial response to locally administered dinoprostone.

Biological Half-LifeLess than 5 minutes.
Metabolism/MetabolitesRapid metabolism of dinoprostone occurs primarily in the local tissues; any systemic absorption of the medication is cleared mainly in the maternal lungs and, secondarily, at sites such as the liver and kidneys.
FDA Pharmacological Classification · 6 件

K7Q1JQR04M

関連反応

42 件
反応記録を作成
HRID 55567 の反応式
HRID 55567反応物として
HRID 436346 の反応式
HRID 436346反応物として
HRID 436347 の反応式
HRID 436347反応物として
HRID 437096 の反応式
HRID 437096反応物として
HRID 437107 の反応式
HRID 437107反応物として
HRID 457460 の反応式
HRID 457460生成物として
HRID 549508 の反応式
HRID 549508生成物として
HRID 619392 の反応式
HRID 619392生成物として
前へ1 / 6 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
UNII
K7Q1JQR04M
EC Number
206-656-6
Nikkaji
J9.243F
沸点
530.1 · 530.1±50.0 °C(Predicted)
比重(密度)
1.148 · 1.148±0.06 g/cm3(Predicted)
酸解離定数(Pka)
4.75 · 4.75±0.10(Predicted)

DINOPROSTONE

Established Pharmacologic Class [EPC] - Prostaglandin Analog

Chemical Structure [CS] - Prostaglandins

Dinoprostone is a Prostaglandin Analog.

DINOPROSTONE

MeSH Pharmacological Classification · 1 件

Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157)

Absorption, Distribution and Excretion · 2 件

Absorbed at a rate of 0.3 mg per hour over 12 hours while the vaginal system is in place.

The major route of elimination of the products of PGE2 metabolism is the kidneys.

Tissue LocationsBrain
Cellular LocationsCytoplasm
Metabolite PathwaysAcetaminophen Action Pathway

用途と製造

UsesUse (kg) in USA (2002): 2